Nemluvio is now the first approved monoclonal antibody that specifically targets interleukin-31 receptor alpha ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback